Keyphrases
Vasodilation
100%
Mast Cells
100%
Pituitary Adenylate Cyclase-activating polypeptide-38
100%
Middle Meningeal Artery
100%
PACAP27
38%
Intracarotid
23%
Vasoactive Intestinal Polypeptide
23%
Control Cell
23%
Intravenous Infusion
23%
Mean Arterial Pressure
15%
Arterial Diameter
15%
Calcitonin Gene-related Peptide
15%
Antihistamines
15%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
15%
Receptor-mediated
7%
Migraineurs
7%
Cell Depletion
7%
Headache
7%
A1 Receptor
7%
H2-receptor Antagonists
7%
Vascular Reactivity
7%
Emax
7%
Mast Cell Degranulation
7%
Facial Flushing
7%
PAC1
7%
Receptor Antagonist
7%
Chronic Treatment
7%
Window Model
7%
Vasodilatory
7%
Histamine
7%
Healthy Volunteers
7%
Long-lasting Effect
7%
Diameter Change
7%
Cranial Window
7%
Increased Dose
7%
Maximum Response
7%
Medicine and Dentistry
Infusion
100%
Hypophysis Adenylate Cyclase Activating Polypeptide
100%
Vasodilatation
100%
Mast Cell
100%
Middle Meningeal Artery
100%
Hypophysis Adenylate Cyclase Activating Polypeptide 27
35%
Vasoactive Intestinal Polypeptide
21%
Intravenous Drug Administration
21%
Mean Arterial Pressure
14%
Calcitonin Gene Related Peptide
14%
Histamine Antagonist
14%
Headache
7%
H2 Antagonist
7%
Receptor
7%
Blood Vessel Reactivity
7%
Compound 48-80
7%
Study Subject
7%
H1 Antagonist
7%
Mediator
7%
Volunteer
7%
Histamine
7%
Receptor Antagonist
7%
Neuroscience
Vasodilation
100%
Middle Meningeal Artery
100%
Hypophysis Adenylate Cyclase Activating Polypeptide
100%
Mast Cell
100%
Hypophysis Adenylate Cyclase Activating Polypeptide 27
35%
Vasoactive Intestinal Peptide
21%
Antihistamines
14%
Calcitonin
14%
Mepyramine
7%
Headache
7%
Receptor
7%
PAC-1
7%
Mast Cell Degranulation
7%
H1 Antagonist
7%
Histamine
7%
Receptor Antagonist
7%
Biochemistry, Genetics and Molecular Biology
Vasodilatation
100%
Pituitary Adenylate Cyclase-Activating Polypeptide
100%
Mast Cell
100%
Vasoactive Intestinal Peptide
21%
Antihistamines
14%
Artery Diameter
14%
Mean Arterial Pressure
14%
Calcitonin Gene-Related Peptide
14%
Histamine
7%
Receptor Antagonist
7%
Blood Vessel Reactivity
7%
H2 Antagonist
7%
Mepyramine
7%
Mast Cell Degranulation
7%
Mediator
7%
Famotidine
7%
Normal Human
7%
PAC-1
7%
Veterinary Science and Veterinary Medicine
Vasodilation
100%
Rat
100%
Mast Cell
100%
Vasoactive Intestinal Peptide
20%
Intravenous Drug Administration
20%
Mean Arterial Pressure
13%
Calcitonin
13%
Pharmacology, Toxicology and Pharmaceutical Science
Hypophysis Adenylate Cyclase Activating Polypeptide
100%
Hypophysis Adenylate Cyclase Activating Polypeptide 27
35%
Vasoactive Intestinal Polypeptide
21%
Antihistaminic Agent
14%
Calcitonin Gene Related Peptide
14%
Receptor Antagonist
7%
Famotidine
7%
Receptor
7%
Histamine H1 Receptor Antagonist
7%
Mepyramine
7%
Compound 48/80
7%
Histamine
7%
Histamine H2 Receptor Antagonist
7%
Headache
7%
Normal Human
7%